Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Sponsor: Alexion Pharmaceuticals, Inc.
Summary
The primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with active or chronic active antibody-mediated rejection (AMR) at Week 52.
Official title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2025-03-07
Completion Date
2028-11-07
Last Updated
2026-04-01
Healthy Volunteers
No
Interventions
ALXN2030
ALXN2030 will be administered subcutaneously (SC).
Placebo
Placebo will be administered SC.
Locations (55)
Research Site
Birmingham, Alabama, United States
Research Site
Scottsdale, Arizona, United States
Research Site
Los Angeles, California, United States
Research Site
Orange, California, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Kansas City, Kansas, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Detroit, Michigan, United States
Research Site
Livingston, New Jersey, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
Durham, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Charleston, South Carolina, United States
Research Site
Dallas, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Richmond, Virginia, United States
Research Site
Seattle, Washington, United States
Research Site
Milwaukee, Wisconsin, United States
Research Site
Botucatu, Brazil
Research Site
Campinas, Brazil
Research Site
Porto Alegre, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
London, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Changsha, China
Research Site
Guangzhou, China
Research Site
Nanning, China
Research Site
Shanghai, China
Research Site
Wuhan, China
Research Site
Xi'an, China
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
Zaragoza, Spain
Research Site
Kaohsiung City, Taiwan
Research Site
Kaohsiung City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Taoyuan District, Taiwan
Research Site
Birmingham, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom